MedPath

Clinical effect of wet application of tripterygium wilfordii granules on psoriasis vulgaris

Phase 1
Not yet recruiting
Conditions
Psoriasis
Registration Number
ITMCTR2100004469
Lead Sponsor
Yueyang integrated traditional Chinese and Western Medicine Hospital Affiliated to Shanghai University of traditional Chinese Medicine
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Pending
Sex
All
Target Recruitment
Not specified
Inclusion Criteria

The results were as follows: 1. The patients who met the diagnostic criteria of psoriasis vulgaris with skin lesion area less than or equal to 10% BSA tended to be aggregated;
2. Subjects who meet the diagnostic criteria of blood heat syndrome of traditional Chinese medicine;
3. Subjects aged >= 18 and <= 79 years, regardless of gender;
4. Patients with informed consent, signed informed consent, discussed through ethics committee, volunteered to receive treatment, observation and examination.

Exclusion Criteria

1. Patients with only head and face lesions, patients with scattered lesions such as drip type, and patients with other active skin diseases may affect the condition evaluators;
2. Patients who received systemic research drugs, biological agents and immunosuppressants within 3 months; He had been treated with glucocorticoid and phototherapy within 2 weeks;
3. Patients in the period of severe uncontrollable local or systemic acute or chronic infection, patients with history of malignant tumor, patients with primary or secondary immunodeficiency and hypersensitivity, patients with severe systemic diseases, patients with severe mental history or family history, or other abnormal patients judged by researchers not suitable for this trial;
4. Patients who have undergone major surgery within 8 weeks or who will need such surgery during the study period;
5. Pregnant or lactating women;
6. Subjects with a history of alcohol, drug or drug abuse;
7. Subjects known to be allergic to Tripterygium wilfordii or calcipotriol, and subjects with calcium metabolism disorder;
8. For other reasons, those subjects that the researchers think are not suitable to participate in this study.

Study & Design

Study Type
Interventional study
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Secondary Outcome Measures
NameTimeMethod

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.